Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection

Recruiting N/A Interventional Study
Liver Tumor; Surgery Primary Liver Tumor, Metastatic Liver Primary Liver Cancer Liver Resection Benign Liver Tumor
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 70
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
74 (estimated)
Sponsor
Warangkana Lapisatepun · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Liver resection is a major surgery that can be associated with significant intraoperative blood loss and blood transfusion. Among high-volume centers, median intraoperative blood loss ranges between 300-800 ml. Excessive blood loss is a strong independent predictor of worsened postoperative outcomes, increasing morbidity and mortality rates by 20%-35%. Additionally, perioperative allogeneic blood …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All genders, age 18 to 70 years old * American Society of Anesthesiologists (ASA) physical status classification of I-III * The patients who scheduled in elective open liver resection and diagnosed Hepatocellular Carcinoma, Cholangiocarcinoma, Liver metastasis, and Benign mali…
Contacts

Worakitti Lapisatepun, MD. PhD.

0910688761

worakitti.l@cmu.ac.th

CONTACT

Worakitti Lapisatepun, MD.

0910688761

worakitti.l@cmu.ac.th

CONTACT